Harmony Sierens
Pediatric Rehabilitation Medicine Grand Blanc, MI Medical Doctor
NPI 1326201252 CMS profile 106107
4632 Genesys Pkwy, Grand Blanc, MI 48439
General payments
$5,828
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$201,209
Through program year 2025, Harmony Sierens of Grand Blanc, MI is reported in the CMS Open Payments database as having received $5,828 across 87 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $201,209 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 91st percentile of Pediatric Rehabilitation Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $4,145 | 23 | |
| 2024 | General | $549 | 24 | |
| 2023 | General | $448 | 19 | |
| 2022 | General | $98 | 2 | |
| 2021 | General | $121 | 1 | |
| 2020 | General | $109 | 3 | |
| 2019 | General | $359 | 15 |
Beside peers
- Harmony Sierens
- Pediatric Rehabilitation Medicine median
- Middle half of Pediatric Rehabilitation Medicine
- National median
In program year 2025, general payments to Harmony Sierens were reported at $4,145. Among 99 Pediatric Rehabilitation Medicine profiles paid that year, the median was $109 and the middle half received between $35 and $182.
Show as a table
| Year | Harmony Sierens | Pediatric Rehabilitation Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $359 | $160 | $37–$360 | $163 |
| 2020 | $109 | $60 | $16–$181 | $114 |
| 2021 | $121 | $108 | $31–$499 | $132 |
| 2022 | $98 | $96 | $36–$215 | $149 |
| 2023 | $448 | $101 | $29–$293 | $160 |
| 2024 | $549 | $77 | $26–$150 | $164 |
| 2025 | $4,145 | $109 | $35–$182 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 25 drugsPart D claims
945
Drug cost
$26,997
Branded share of claims
31.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycontin Oxycodone Hcl | Brand | 19 | $10,501 | |
| Gabapentin | Generic | 161 | $3,121 | |
| Pregabalin | Generic | 52 | $2,093 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 151 | $2,030 | |
| Baclofen | Generic | 90 | $1,692 | |
| Celecoxib | Generic | 13 | $1,506 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 53 | $950 | |
| Diazepam | Generic | 18 | $783 | |
| Oxycodone Hcl | Generic | 45 | $766 | |
| Morphine Sulfate Er Morphine Sulfate | Brand | 49 | $661 |
The 10 drugs with the highest cost, of 25 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$176,265
Medicare patients
174
Services billed
12,178
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 58% | |
| Diabetes | 51% | |
| Ischemic heart disease | 51% | |
| Heart failure | 48% | |
| Chronic kidney disease | 43% | |
| Atrial fibrillation | 41% | |
| Depression | 41% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, abobotulinumtoxina, 5 units J0586 | Office | 14 | 8,440 | $57,538 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
5 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| DYSPORT |
|
$280 | — | 8,440 |
| BOTOX |
|
$141 | — | — |
| Qutenza |
|
$73 | — | — |
| UBRELVY |
|
$19 | — | — |
| QULIPTA |
|
$11 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
87 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Rehabilitation Medicine in Michigan
Charles Pelshaw
Pediatric Rehabilitation Medicine · Detroit, MI
Andrea Kuldanek
Pediatric Rehabilitation Medicine · Grand Rapids, MI
Lisa Voss
Pediatric Rehabilitation Medicine · Grand Rapids, MI
Douglas Henry
Pediatric Rehabilitation Medicine · Grand Rapids, MI
Christina Santia
Pediatric Rehabilitation Medicine · Detroit, MI
Susan Youngs
Pediatric Rehabilitation Medicine · Dearborn, MI
Related records
Pediatric Rehabilitation Medicine in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Rehabilitation Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.